Constitutive resistance to viral infection in human CD141 + dendritic cells
Author(s) -
Aymeric Silvin,
Chun I. Yu,
Xavier Lahaye,
Francesco Imperatore,
JeanBaptiste Brault,
Sylvain Cardinaud,
Christian Becker,
Wing-Hong Kwan,
Cécile Conrad,
Mathieu Maurin,
Christel Goudot,
Santy Marques-Ladeira,
Yuanyuan Wang,
Virginia Pascual,
Esperanza Anguiano,
Randy A. Albrecht,
Matteo Iannacone,
Adolfo Garcı́a-Sastre,
Bruno Goud,
Marc Dalod,
Arnaud Moris,
Miriam Mérad,
Karolina Palucka,
Nicolas Manel
Publication year - 2017
Publication title -
science immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.83
H-Index - 51
ISSN - 2470-9468
DOI - 10.1126/sciimmunol.aai8071
Subject(s) - biology , immune system , antigen presentation , virology , bystander effect , acquired immune system , dendritic cell , antigen , immunity , immunology , innate immune system , viral interference , virus , cross presentation , t cell , viral replication
Dendritic cells (DCs) are critical for the launching of protective T cell immunity in response to viral infection. Viruses can directly infect DCs, thereby compromising their viability and suppressing their ability to activate immune responses. How DC function is maintained in light of this paradox is not understood. By analyzing the susceptibility of primary human DC subsets to viral infections, we report that CD141 + DCs have an innate resistance to infection by a broad range of enveloped viruses, including HIV and influenza virus. In contrast, CD1c + DCs are susceptible to infection, which enables viral antigen production but impairs their immune functions and survival. The ability of CD141 + DCs to resist infection is conferred by RAB15, a vesicle-trafficking protein constitutively expressed in this DC subset. We show that CD141 + DCs rely on viral antigens produced in bystander cells to launch cross-presentation-driven T cell responses. By dissociating viral infection from antigen presentation, this mechanism protects the functional capacity of DCs to launch adaptive immunity against viral infection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom